Literature DB >> 8062211

Inhibition of carcinogen-induced pulmonary and mammary carcinogenesis by chalcone administered subsequent to carcinogen exposure.

L W Wattenberg1, J B Coccia, A R Galbraith.   

Abstract

A study of the capacity of chalcone to inhibit benzo[alpha]pyrene(BP)-induced carcinogenesis of the lungs and forestomach in female A/J mice and N-methyl-N-nitrosourea (MNU)-induced mammary carcinogenesis in female Sprague-Dawley rats has been carried out. Chalcone, 5 mg/g of diet, had a inhibitory effect on pulmonary adenoma formation (29%) and on mammary tumor formation (49%) when the compound was fed starting one week after final carcinogen administration. Chalcone did not inhibit forestomach tumor formation. In an additional study, chalcone started 4 weeks after MNU and fed for 3-week courses alternating with 3-week courses of control diet for the duration of the protocol also inhibited mammary tumor formation by 49%. The data showing that chalcone has inhibitory effects against both pulmonary and mammary carcinogenesis when given after carcinogen administration provides the basis for further investigations of this and possibly other chalcones as chemopreventive suppressing agents.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8062211     DOI: 10.1016/0304-3835(94)90314-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  A comparative study of conventional and supercritical fluid extraction methods for the recovery of secondary metabolites from Syzygium campanulatum Korth.

Authors:  Abdul Hakeem Memon; Mohammad Shahrul Ridzuan Hamil; Madeeha Laghari; Fahim Rithwan; Salman Zhari; Mohammed Ali Ahmed Saeed; Zhari Ismail; Amin Malik Shah Abdul Majid
Journal:  J Zhejiang Univ Sci B       Date:  2016-09       Impact factor: 3.066

Review 2.  Hormetic dietary phytochemicals.

Authors:  Tae Gen Son; Simonetta Camandola; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2008-06-10       Impact factor: 3.843

3.  Dual targeting of MDM2 with a novel small-molecule inhibitor overcomes TRAIL resistance in cancer.

Authors:  Anup Kumar Singh; Shikha S Chauhan; Sudhir Kumar Singh; Ved Vrat Verma; Akhilesh Singh; Rakesh Kumar Arya; Shrankhla Maheshwari; Md Sohail Akhtar; Jayanta Sarkar; Vivek M Rangnekar; Prem M S Chauhan; Dipak Datta
Journal:  Carcinogenesis       Date:  2016-11-01       Impact factor: 4.944

4.  Biotransformation of the chemopreventive agent 2',4',4-trihydroxychalcone (isoliquiritigenin) by UDP-glucuronosyltransferases.

Authors:  Jian Guo; Ang Liu; Hongmei Cao; Yan Luo; John M Pezzuto; Richard B van Breemen
Journal:  Drug Metab Dispos       Date:  2008-07-24       Impact factor: 3.922

5.  Isolation, Characterization, Crystal Structure Elucidation, and Anticancer Study of Dimethyl Cardamonin, Isolated from Syzygium campanulatum Korth.

Authors:  Abdul Hakeem Memon; Zhari Ismail; Abdalrahim F A Aisha; Fouad Saleih Resq Al-Suede; Mohammad Shahrul Ridzuan Hamil; Suzana Hashim; Mohammed Ali Ahmed Saeed; Madeeha Laghari; Amin Malik Shah Abdul Majid
Journal:  Evid Based Complement Alternat Med       Date:  2014-10-28       Impact factor: 2.629

6.  Pharmacokinetic evaluation of Chalcone derivatives with antimalarial activity in New Zealand White Rabbits.

Authors:  Shweta Sinha; Ajay Prakash; Bikash Medhi; Alka Sehgal; Daniela I Batovska; Rakesh Sehgal
Journal:  BMC Res Notes       Date:  2021-07-08

7.  4-Hy-droxy-6-methyl-3-[3-(thio-phen-2-yl)acrylo-yl]-2H-pyran-2-one.

Authors:  Salima Thabti; Amel Djedouani; Abderrahmen Bendaas; Sihem Boufas; Rémi Loui; Dominique Mandon
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.